Richard A. Forshee

Deputy Director
Office of Biostatistics and Pharmacovigilance, Center for Biologics Evaluation and Research

Poster(s):

• (A-329) Safety Monitoring of Health Outcomes following Influenza Vaccination during the 2023–2024 Season among U.S. individuals aged 6 months through 64 years
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (B-308) Safety Monitoring of Mpox Vaccines in Adults Aged 18–64 Years during the 2022 Mpox Outbreak in the U.S.
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (A-331) Safety Monitoring of Multiple Health Outcomes following 2023–2024 COVID-19 Vaccination among Commercial Health Plan Enrollees Aged 6 Months–64 Years in the United States
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET